'MUST. CONNECT 2023' kicked off on October 11, 2023 at Singapore Science Park for a two-day event aimed at supporting Korean startups' global expansion. This year’s focus is on biotech and digital healthcare, featuring 12 selected Korean startups showcasing innovations such as AI-driven brain structure analysis (Neurophet), electroceutical depression treatment (Neurive), and autoimmune therapeutics (ImmunAbs). Global pharmaceutical companies like Johnson & Johnson, Sanofi CHC, and Organon, along with Singapore-based venture investors, joined to explore investment and collaboration opportunities. Ji-sun Lee, CEO of MUST Accelerator, highlighted Singapore as a key gateway for Korean startups seeking global growth.
'MUST. CONNECT 2023' kicked off on October 11, 2023 at Singapore Science Park for a two-day event aimed at supporting Korean startups' global expansion. This year’s focus is on biotech and digital healthcare, featuring 12 selected Korean startups showcasing innovations such as AI-driven brain structure analysis (Neurophet), electroceutical depression treatment (Neurive), and autoimmune therapeutics (ImmunAbs). Global pharmaceutical companies like Johnson & Johnson, Sanofi CHC, and Organon, along with Singapore-based venture investors, joined to explore investment and collaboration opportunities. Ji-sun Lee, CEO of MUST Accelerator, highlighted Singapore as a key gateway for Korean startups seeking global growth.
View Original Article